Cases selected for the AskAnzal weekly PMCPA insight newsletter
A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate…
PMCPA case AUTH/2613/6/13 about a Cerazette discount scheme. The matter was found to be outwith the scope of…
GSK disclosed that Avandamet ads ran for ~3 months with outdated prescribing information omitting macular oedema as a…
A hospital doctor said an Imraldi mailing requiring a signature was harassment and an inappropriate marketing practice. Panel…
Anonymous complaint about an unsolicited MSL email to an NHS address during COVID-19. Panel found the email was…
RCGP Overdiagnosis Group challenged a Pfizer/BMS Eliquis email promoting AF pulse checks at flu clinics for over-65s, alleging…
LEO discovered four cross-border transfers of value involving three UK patient organisations. Three 2019 payments were disclosed late…
A UK health professional complained that the Ajovy website entry pop-up lacked the generic name and black triangle.…
Pulse ad for Trixeo linked COPD exacerbations and death with a βTake action with Trixeoβ call-to-action, creating an…
PMCPA case AUTH/3728/1/23: complaint alleging promotion of Zeposia (ozanimod hydrochloride) against Bristol Myers Squibb. Outcome: no breach; matter…
One real case. One key lesson. Every week β free.